Skip to main content

Table 2 Prevalent medications (ATC) upon admission and discharge after hip fracture surgery (n = 272)

From: Polypharmacy and adverse outcomes after hip fracture surgery

ATC-code medication

Admission (n)

Discharge (n)

Difference (n)

A02B drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)

79

82

−3

B01AA vitamin K antagonists

13

12

−1

B01AB heparin group

1

90

+89

B01AC platelet aggregation inhibitors

108

89

−19

C01D vasodilators, (nitrates)

34

40

+6

C03 diuretics, all

113

66

−47

C03A low-ceiling diuretics (thiazides)

35

17

−18

C03C high ceiling diuretics (loop)

72

37

−35

C03D potassium-sparing agents (C03DA, aldosterone antagonists)

31

11

−20

C07A beta-blocking agents

85

84

−1

C08C-D calcium channel blockers

55

31

−24

C09A-C agents acting on the renin-angiotensin system

72

62

−10

C01-09 antihypertensives

179

148

−31

M05B drugs affecting bone structure and mineralization

68

83

+15

N02A opioids strong

(excl. tramadol)

14

45

+31

N02AX opioids weak (tramadol)

13

160

+147

N02B other analgesics (incl. paracetamol)

63

220

+157

N04B dopaminergic agents (antiparkinson)

15

15

+/−0

N05B anxiolytics (incl. benzodiazepines)

56

48

−8

N05C hypnotics and sedatives (incl. zolpidem and heminevrin)

80

78

−2

N06A antidepressants, totally

80

79

−1

N06AB SSRI only

66

63

−3

N06D psychoanaleptics (antidementia)

15

14

−1

R03A-B drugs for obstructive airway diseases

28

28

+/−0

S01E-X ophtalmologicals (eye drops)

31

31

+/−0